Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications
In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.
Reassuring Data on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antipsychotic Medications
Two studies - one using neuropsychological assessments, another examining performance on standardized testing - show no association between prenatal antipsychotic exposure and neurodevelopmental outcomes.